XML 81 R65.htm IDEA: XBRL DOCUMENT v3.4.0.3
Share-Based Compensation (Details)
3 Months Ended
Mar. 31, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $ / shares $ 20.97
Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividend yield 1.90%
Expected volatility 19.50%
Risk-free interest rate 1.00%
Expected holding period 4 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of period | shares 11,047,920
Options outstanding at beginning of period, weighted average exercise price | $ / shares $ 13.98
Granted | shares 1,036,522
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares $ 22.28
Exercised | shares 417,383
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares $ 7.51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares (7,064)
Options outstanding at end of period | shares 11,659,995
Options outstanding at end of period, weighted average exercise price | $ / shares $ 14.94
Options exercisable at end of period | shares 8,559,885
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares $ 12.62
Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Nonvested restricted shares at beginning of period | shares 573,739
Nonvested restricted shares at beginning of period, weighted average grant date fair value | $ / shares $ 19.32
Other than Options, Grants in Period | shares 241,510
Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 22.28
Other than Options, Vested in Period | shares (306,000)
Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 18.06
Other than Options, Forfeited in Period | shares 1,258
Other than Options, Forfeitures, Weighted Average | $ / shares $ 20.85
Nonvested restricted shares at end of period | shares 507,991
Nonvested restricted shares at end of period, weighted average grant date fair value | $ / shares $ 21.48